Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: Long term follow up of the first series of 25 patients

Heart

Volumn 83, Issue 3, 2000, Pages 326-331

  Faber, L ^a   Meissner, A ^a   Ziemssen, P ^a   Seggewiss, H ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Hypertrophic obstructive cardiomyopathy; Left ventricular outflow tract gradient; Myocardial contrast echocardiography; Percutaneous transluminal septal myocardial ablation

Indexed keywords

ALCOHOL; CREATINE KINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORONARY ARTERY; ECHOCARDIOGRAPHY; FEMALE; HEART BLOCK; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART PACING; HEART SURGERY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PERCUTANEOUS TRANSLUMINAL SEPTAL MYOCARDIAL ABLATION; PRIORITY JOURNAL; SURGICAL ANATOMY;

EID: 0034021370     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.83.3.326     Document Type: Article

References (25)

1. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-14.
2. Gleichmann U, Seggewiss H, Faber L, et al. Kathetertherapie der hypertrophen obstruktiven Kardiomyopathie. Dtsch Med Wochenschr 1996;121:679-85.
3. Knight CJ, Kurbaan AS, Seggewiss H, et al. Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients. Circulation 1997;95:2075-81.
4. Kuhn H, Gietzen F, Leuner C, et al. Induction of subaortic septal ischemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Eur Heart J 1997;18:846-51.
5. Seggewiss H, Gleichmann U, Faber L, et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-months follow-up in 25 patients. J Am Coll Cardiol 1998;31:252-8.
6. Faber L, Seggewiss H, Fassbender D, et al. Catheter treatment in hypertrophic obstructive cardiomyopathy: identification of the perfusion area of septal branches by myocardial contrast echocardiography [abstract]. Eur Heart J 1997;18(suppl):368.
7. Faber L, Seggewiss H, Fassbender D, et al. Guiding of PTSMA in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography: a case report. Journal of Interventional Cardiology 1998;11:443-8.
8. Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intra-procedural myocardial contrast echocardiography. Circulation 1998;98:2415-21.
9. Spirito P, Seidman CE, Mc Kenna WJ, et al. The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775-85.
10. Wigle DE, Rakowski H, Kimball BP, et al. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 1995;92:1680-92.
11. Sahn DJ, De Maria AN, Kisslo J, et al. The committee on M-mode standardization of the American Society of Echo-cardiography. Circulation 1978;58:1072-83.
12. Pollick C, Rakowsky H, Wigle ED. Muscular subaortic stenosis: the quantitative relationship between SAM and the pressure gradient. Circulation 1984;69:43-9.
13. Takayi E, Yamakado T, Nakano T. Prognosis of completely asymptomatic adult patients with HOCM. J Am Coll Cardiol 1999;33:206-11.
14. Morrow AG, Brockenbrough EC. Surgical treatment of idiopathic hypertrophic subaortic stenosis: Technique and hemodynamic results of subaortic ventriculotomy. Ann Surg 1961;154:181-9.
15. Robbins RC, Stinson EB, Daily PO. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 1996;111:86-94.
16. Mc Cully RB, Nishimura RA, Tajik AJ, et al. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 1996;94:467-71.
17. Fananapazir L, Epstein ND, Curiel RV, et al. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Circulation 1994;90:2731-42.
18. Kappenberger L, Linde C, Daubert C, et al and the PIC Study Group. Pacing in hypertrophic obstructive cardiomyopathy. Eur Heart J 1997;18:1249-56.
19. Nishimura RA, Hayes DL, Ilstrup D, et al. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy: acute Doppler echocardiographic and catheterization hemodynamic study. J Am Coll Cardiol 1996;27:421-30.
20. Gadler F, Linde C, Ryden L. Rapid return of LVOT obstruction and symptoms following cessation of long-term AV synchronous pacing for HOCM. Am J Cardiol 1999;83:513-8.
21. Braunwald E. Induced septal infarction: a new strategy for hypertrophic obstructive cardiomyopathy. Circulation 1997;95:1981-2.
22. Brugada P, De Swart H, Smeets JLRM, et al. Transcoronary chemical ablation of ventricular tachycardia. Circulation 1989;79:475-82.
23. Gietzen F, Leuner C, Gerenkamp T, et al. Relief of obstruction in hypertrophic cardiomyopathy by transient occlusion of the first septal branch of the left coronary artery [abstract]. Eur Heart J 1994;15:125.
24. Seggewiss H, Faber L, Gleichmann U, et al. Remodeling after percutaneous transluminal septal myocardial ablation in HOCM results in ongoing outflow tract gradient reduction [abstract]. J Am Coll Cardiol 1999;33(suppl 2):A490.
25. Hina K, Kusachi S, Iwasaka K, et al. Progression of left ventricular enlargement in patients with hypertrophic cardiomyopathy: incidence and prognostic value. Clin Cardiol 1993;16:403-7.